Literature DB >> 28972930

Insomnia and hypersomnia in major depressive episode: Prevalence, sociodemographic characteristics and psychiatric comorbidity in a population-based study.

Pierre A Geoffroy1, Nicolas Hoertel2, Bruno Etain3, Frank Bellivier3, Richard Delorme4, Frédéric Limosin2, Hugo Peyre5.   

Abstract

OBJECTIVES: To examine (i) the frequency of different sleep complaints (early wake-up, trouble falling asleep, hypersomnia) and their co-occurrence and (ii) the sociodemographic characteristics and psychiatric comorbidity associated with each type of sleep profiles.
METHODS: Data were drawn from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions, a nationally representative survey of the US adult population (wave 1, 2001-2002; wave 2, 2004-2005). The primary analyses were limited to 3573 participants who had a DSM-IV-TR diagnosis of major depressive episode (MDE) between the two waves. We used a multiple regression model to estimate the strength of independent associations between self-reported sleep complaints, sociodemographic characteristics and lifetime psychiatric comorbidity.
RESULTS: Most of participants with MDE (92%) reported significant sleep complaints, from whom 85.2% had insomnia and 47.5% hypersomnia symptoms. The prevalence rates were for insomnia "only" of 48.5%, hypersomnia "only" of 13.7%, and their co-occurrence of 30.2%. We found that several sociodemographic characteristics (gender, age, education, individual and familial income, marital status) and psychiatric disorders (bipolar disorders, post-traumatic disorders and panic disorder) were significantly and independently associated with different sleep profiles. The co-occurrence of insomnia (especially early wake-up) and hypersomnia presented with a two-/three- fold increase risk of bipolar disorders. LIMITATIONS: Definitions of sleep complaints were qualitative and subjective.
CONCLUSION: Sleep complaints are prevalent and heterogeneous in expression during MDE. Sleep disturbance profiles are associated with specific patterns of comorbidity. Our findings highlight the importance of continued research on sleep complaints during MDE while taking into account psychiatric comorbidity.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Depression; Hypersomnia; Insomnia; Major depressive disorder; Sleep disturbance

Mesh:

Year:  2017        PMID: 28972930     DOI: 10.1016/j.jad.2017.09.032

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  27 in total

1.  Concurrent use of benzodiazepines, antidepressants, and opioid analgesics with zolpidem and risk for suicide: a case-control and case-crossover study.

Authors:  Hi Gin Sung; Junquing Li; Jin Hyun Nam; Dae Yeon Won; BongKyoo Choi; Ju-Young Shin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-04-29       Impact factor: 4.328

2.  Sleep disturbance and physiological regulation among young adults with prior depression.

Authors:  Jessica L Hamilton; Jonathan P Stange; Taylor A Burke; Peter L Franzen; Lauren B Alloy
Journal:  J Psychiatr Res       Date:  2019-05-16       Impact factor: 4.791

3.  An Integrated Sleep and Reward Processing Model of Major Depressive Disorder.

Authors:  Elaine M Boland; Jennifer R Goldschmied; Emily Wakschal; Robin Nusslock; Philip R Gehrman
Journal:  Behav Ther       Date:  2020-01-13

4.  Treating sleep and circadian problems to promote mental health: perspectives on comorbidity, implementation science and behavior change.

Authors:  Allison G Harvey
Journal:  Sleep       Date:  2022-04-11       Impact factor: 5.849

5.  Is Agomelatine Associated with Less Sedative-Hypnotic Usage in Patients with Major Depressive Disorder? A Nationwide, Population-Based Study.

Authors:  Shih-Chun Hsing; Yo-Ting Jin; Nian-Sheng Tzeng; Chi-Hsiang Chung; Tien-Yu Chen; Hsin-An Chang; Yu-Chen Kao; Wu-Chien Chien
Journal:  Neuropsychiatr Dis Treat       Date:  2020-07-22       Impact factor: 2.570

6.  Development and validation of the Hypersomnia Severity Index (HSI): A measure to assess hypersomnia severity and impairment in psychiatric disorders.

Authors:  Katherine A Kaplan; David T Plante; Jesse D Cook; Allison G Harvey
Journal:  Psychiatry Res       Date:  2019-08-31       Impact factor: 3.222

7.  Sleep complaints are associated with increased suicide risk independently of psychiatric disorders: results from a national 3-year prospective study.

Authors:  Pierre A Geoffroy; Maria A Oquendo; Philippe Courtet; Carlos Blanco; Mark Olfson; Hugo Peyre; Michel Lejoyeux; Frédéric Limosin; Nicolas Hoertel
Journal:  Mol Psychiatry       Date:  2020-04-30       Impact factor: 13.437

8.  Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers.

Authors:  Dmitriy Matveychuk; Rejish K Thomas; Jennifer Swainson; Atul Khullar; Mary-Anne MacKay; Glen B Baker; Serdar M Dursun
Journal:  Ther Adv Psychopharmacol       Date:  2020-05-11

9.  Evaluation of the effect of insulin sensitivity-enhancing lifestyle- and dietary-related adjuncts on antidepressant treatment response: protocol for a systematic review and meta-analysis.

Authors:  Olaitan J Jeremiah; Gráinne Cousins; Finbarr P Leacy; Brian P Kirby; Benedict K Ryan
Journal:  Syst Rev       Date:  2019-02-25

10.  Generalized Anxiety disorder but not depression is associated with insomnia: a population based study.

Authors:  Imran Wasfi Khan; Ruchi Juyal; Deep Shikha; Ravi Gupta
Journal:  Sleep Sci       Date:  2018 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.